GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
D82.3
Immunodeficiency following hereditary defective response to Epstein-Barr virus
ICD10CM code
Medical Policies and Guidelines for Immunodeficiency following hereditary defective response to Epstein-Barr virus
Related policies from health plans
ANTHEM-BLUECROSS-CA
Nulojix (belatacept)
ANTHEM-BLUECROSS-CT
TRANS.00029 Hematopoietic Stem Cell Transplantation for Genetic Diseases and Aplastic Anemias
ANTHEM-BLUECROSS-CT
TRANS.00029 Hematopoietic Stem Cell Transplantation for Genetic Diseases and Aplastic Anemias
ANTHEM-BLUECROSS-CT
TRANS.00029 Hematopoietic Stem Cell Transplantation for Genetic Diseases and Aplastic Anemias
Similar Codes
ICD10CM codes
D82.3
- Immunodeficiency following hereditary defective response to Epstein-Barr virus
D80.9
- Immunodeficiency with predominantly antibody defects, unspecified
D80
- Immunodeficiency with predominantly antibody defects
D80.8
- Other immunodeficiencies with predominantly antibody defects
D82.9
- Immunodeficiency associated with major defect, unspecified
D82.8
- Immunodeficiency associated with other specified major defects
D84.9
- Immunodeficiency, unspecified
D82
- Immunodeficiency associated with other major defects
D84.89
- Other immunodeficiencies
D81.9
- Combined immunodeficiency, unspecified
HCPCS codes
G0432
- Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, scree
G0433
- Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 an
G9223
- Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below
J0850
- Injection, cytomegalovirus immune globulin intravenous (human), per vial
G0472
- Hepatitis c antibody screening, for individual at high risk and other covered indication(s)
G0435
- Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening
G9416
- Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the
J7599
- Immunosuppressive drug, not otherwise classified
J9311
- Injection, rituximab 10 mg and hyaluronidase
G9359
- Documentation of negative or managed positive tb screen with further evidence that tb is not active
CPT4 codes
86664
- Antibody; Epstein-Barr (EB) virus, nuclear antigen (EBNA)
86665
- Antibody; Epstein-Barr (EB) virus, viral capsid (VCA)
86663
- Antibody; Epstein-Barr (EB) virus, early antigen (EA)
86688
- Antibody; HTLV-II
86687
- Antibody; HTLV-I
86747
- Antibody; parvovirus
86644
- Antibody; cytomegalovirus (CMV)
86645
- Antibody; cytomegalovirus (CMV), IgM
86711
- Antibody; JC (John Cunningham) virus
86762
- Antibody; rubella